Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human... see more

TSXV:CZO - Post Discussion

Ceapro Inc > AGM
View:
Post by boazklinghorn on Apr 10, 2023 11:34am

AGM

Just remember everyone as we drift down into the 50 cent range that we were all here last year and the year before that with a chance to make our voices heard and we didnt. Every year we have some interesting lab results and pipeline potential and  we all meet here going into the AGM to debate wether we have waited long enough for any signs of progress or even any urgency in bringing a new product to the market. I think this is year 12 or 13 of the PGX patent. 8 years to go and nothing to show. For me I have been waiting 4 years, some of you have been much longer. So again we have our chance to demand something better. After this Gilles and Co will go dark again and ignore us for another year. Take this moment or we will be having this discussion yet again in 2024.
Comment by prophetoffactz on Apr 10, 2023 11:58am
boazklinghorn "or even any urgency in bringing a new product to the market." CZO has announced a budget of $6-$7.5 million to scale-up PGX, for the avenanthramide clinical trial, and for scaling up avenanthramide for food applications, etc., and boazklinghorn calls Gilles "lazy" and can't see any "urgency" in bringing products to market? That would be up to 58 ...more  
Comment by boazklinghorn on Apr 10, 2023 12:24pm
Symrise issued a boiler plate statement when they resigned CZO as companies always do so dont read more into it than is there. All the other potential you list is just like it has always been. If you cast your mind back you will remeber when  OBG was the thing and the German plant was coming and the other CoQ10 drink was inches from being sold. We have been hearing about disloving algenate ...more  
Comment by PBaelishh on Apr 10, 2023 2:41pm
I think prophet may be Gilles... or Jenene perhaps?
Comment by Hopeforthebest on Apr 10, 2023 6:13pm
no just their mouthpiece he does not have brains to (Dunning Kruger Effect) to post what he does just passes on information that he is given.
Comment by Alex1726 on Apr 10, 2023 7:01pm
He is Gagnon's parrot. This guy has zero credibility.
Comment by boazklinghorn on Apr 10, 2023 12:56pm
Oh and quit with the ABCL nonsense. Another little Canadain  company less then half as old as CZO grown to a 2 Billion US market cap. In the last three years ABCL made 5 times the income CZO has made in its entire existence. They are in partnership with just about every major pharmaco in the world oh and they have 900 million US in the bank and are building out the worlds best antibody ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities